PRVB logo

Provention Bio (PRVB) Cash From Operations

PRVB Annual CFO

-$75.41 M
+$19.98 M+20.94%

31 December 2022

PRVB Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PRVB Quarterly CFO

-$7.97 M
+$15.99 M+66.73%

31 December 2022

PRVB Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PRVB TTM CFO

-$75.41 M
+$15.48 M+17.03%

31 December 2022

PRVB TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PRVB Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+20.9%+66.0%+20.9%
3 y3 years-109.1%+18.1%-109.1%
5 y5 years-1444.6%-150.7%-109.1%

PRVB Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time+1444.6%<-9999.0%<-9999.0%

Provention Bio Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2022
-$75.41 M(-20.9%)
-$7.97 M(-66.7%)
-$75.41 M(-17.0%)
Sept 2022
-
-$23.97 M(-15.7%)
-$90.89 M(-1.5%)
June 2022
-
-$28.44 M(+89.2%)
-$92.27 M(-1.8%)
Mar 2022
-
-$15.03 M(-35.9%)
-$93.93 M(-1.5%)
Dec 2021
-$95.39 M(+25.0%)
-$23.46 M(-7.5%)
-$95.39 M(-1.2%)
Sept 2021
-
-$25.35 M(-15.8%)
-$96.56 M(+0.6%)
June 2021
-
-$30.09 M(+82.5%)
-$95.97 M(+14.7%)
Mar 2021
-
-$16.49 M(-33.1%)
-$83.66 M(+9.6%)
Dec 2020
-$76.34 M(+111.7%)
-$24.63 M(-0.5%)
-$76.34 M(+24.2%)
Sept 2020
-
-$24.76 M(+39.3%)
-$61.45 M(+34.4%)
June 2020
-
-$17.77 M(+93.9%)
-$45.71 M(+20.6%)
Mar 2020
-
-$9.17 M(-5.9%)
-$37.90 M(+5.1%)
DateAnnualQuarterlyTTM
Dec 2019
-$36.06 M(+59.3%)
-$9.74 M(+8.0%)
-$36.06 M(+12.4%)
Sept 2019
-
-$9.02 M(-9.5%)
-$32.10 M(+10.7%)
June 2019
-
-$9.97 M(+35.9%)
-$29.00 M(+20.9%)
Mar 2019
-
-$7.33 M(+26.9%)
-$23.99 M(+5.9%)
Dec 2018
-$22.64 M(+363.8%)
-$5.78 M(-2.4%)
-$22.64 M(+13.0%)
Sept 2018
-
-$5.92 M(+19.5%)
-$20.05 M(+31.7%)
June 2018
-
-$4.96 M(-17.2%)
-$15.22 M(+40.0%)
Mar 2018
-
-$5.99 M(+88.2%)
-$10.87 M(+122.7%)
Dec 2017
-$4.88 M
-$3.18 M(+191.3%)
-$4.88 M(+187.0%)
Sept 2017
-
-$1.09 M(+79.3%)
-$1.70 M(+179.3%)
June 2017
-
-$609.00 K(<-9900.0%)
-$609.00 K(<-9900.0%)
Mar 2017
-
$0.00
$0.00

FAQ

  • What is Provention Bio annual cash flow from operations?
  • What is the all time high annual CFO for Provention Bio?
  • What is Provention Bio annual CFO year-on-year change?
  • What is Provention Bio quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Provention Bio?
  • What is Provention Bio quarterly CFO year-on-year change?
  • What is Provention Bio TTM cash flow from operations?
  • What is the all time high TTM CFO for Provention Bio?
  • What is Provention Bio TTM CFO year-on-year change?

What is Provention Bio annual cash flow from operations?

The current annual CFO of PRVB is -$75.41 M

What is the all time high annual CFO for Provention Bio?

Provention Bio all-time high annual cash flow from operations is -$4.88 M

What is Provention Bio annual CFO year-on-year change?

Over the past year, PRVB annual cash flow from operations has changed by +$19.98 M (+20.94%)

What is Provention Bio quarterly cash flow from operations?

The current quarterly CFO of PRVB is -$7.97 M

What is the all time high quarterly CFO for Provention Bio?

Provention Bio all-time high quarterly cash flow from operations is $0.00

What is Provention Bio quarterly CFO year-on-year change?

Over the past year, PRVB quarterly cash flow from operations has changed by +$15.48 M (+66.00%)

What is Provention Bio TTM cash flow from operations?

The current TTM CFO of PRVB is -$75.41 M

What is the all time high TTM CFO for Provention Bio?

Provention Bio all-time high TTM cash flow from operations is $0.00

What is Provention Bio TTM CFO year-on-year change?

Over the past year, PRVB TTM cash flow from operations has changed by +$19.98 M (+20.94%)